A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Solid Tumors|Breast Cancer|Recurrent Ovarian Cancer|Prostate Cancer
Interventions: DRUG: VIO-01
Sponsor: Valerio Therapeutics